speb/financial-data huggingface dataset:
Financial ratios for CNTY — quarterly report dated 2025-06-30
Total revenue: 150818000
Gross profit: 65122000
Operating income: 16575000
Net income: -9573000
Capital expenditures: 5809000
Operating cash flow: 11282000
Depreciation & amortization: 12843000
Net tangible assets: -160921000
Owner earnings: -2539000
Capex to operating income (%): 35.04675716440423
Buffett classification: The Good
Stock price: 2.12
Shares outstanding: 28133538
Book value: 50199000
P/B ratio: 1.1881332409012133
Market cap (USD): 59643100.56
Debt to equity: 21.52078726667862
Current ratio: 1.416264988721358
Quick ratio: 1.3730618544461592
Interest coverage ratio: 0.632368089733318
COGS to revenue (%): 56.82146693365513
SG&A to revenue (%): 23.673566815632086
Free cash flow (dilution-adjusted): 5277000
Buyback yield (%): 1.5911312307537082
Retained earnings: -152025000
Inventory turnover: 23.54960153888431
Receivables turnover: 11.29976773806848
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.4743542417371673
FCF margin (%): 3.498919227147953
Revenue growth (%): 15.619849282828516
Rule of 40 score: 19.11876850997647
Financial ratios for CNTY — quarterly report dated 2025-09-30
Total revenue: 153724000
Gross profit: 66993000
Operating income: 17126000
Net income: -9395000
Capital expenditures: 4876000
Operating cash flow: 144000
Depreciation & amortization: 12817000
Net tangible assets: -168946000
Owner earnings: -1454000
Capex to operating income (%): 28.471330141305618
Buffett classification: The Good
Stock price: 2.61
Shares outstanding: 28133538
Book value: 12356000
P/B ratio: 5.942743135318873
Market cap (USD): 73428534.17999999
Debt to equity: 87.34719974101651
Current ratio: 1.4403184420027633
Quick ratio: 1.3922626488584775
Interest coverage ratio: 0.6482701188583542
COGS to revenue (%): 56.419947438265986
SG&A to revenue (%): 24.101636699539434
Free cash flow (dilution-adjusted): -5048000
Buyback yield (%): 2.068678092192852
Retained earnings: -188004000
Inventory turnover: 23.748904709748082
Receivables turnover: 12.70971475816453
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.5814809924010236
FCF margin (%): -3.2838073430303663
Revenue growth (%): 1.926825710458964
Rule of 40 score: -1.3569816325714024
Financial ratios for CNTY — quarterly report dated 2025-12-31
Total revenue: 137991000
Gross profit: 58713000
Operating income: 10439000
Net income: -16049000
Capital expenditures: 4577000
Operating cash flow: -114000
Depreciation & amortization: 12868000
Net tangible assets: -186116000
Owner earnings: -7758000
Capex to operating income (%): 43.84519589999042
Buffett classification: The Good
Stock price: 1.33
Shares outstanding: 28133538
Book value: -6782000
Market cap (USD): 37417605.54
Debt to equity: -159.5041285756414
Current ratio: 1.3044873401855102
Quick ratio: 1.2608423163700175
Interest coverage ratio: 0.399686040278735
COGS to revenue (%): 57.45157292866926
SG&A to revenue (%): 25.658195099680412
Free cash flow (dilution-adjusted): -5017000
Buyback yield (%): 4.030188405262663
Retained earnings: -205950000
Inventory turnover: 22.767949454336588
Receivables turnover: 11.538673802157371
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.9779005162572799
FCF margin (%): -3.6357443601394293
Revenue growth (%): -10.234576253545315
Rule of 40 score: -13.870320613684743
Financial ratios for CNTY — annual report dated 2025-12-31
Total revenue: 572975000
Gross profit: 246449000
Operating income: 51279000
Net income: -53896000
Capital expenditures: 21951000
Operating cash flow: 6688000
Depreciation & amortization: 50921000
Net tangible assets: -186116000
Owner earnings: -24926000
Capex to operating income (%): 42.80699701632248
Buffett classification: The Good
Stock price: 1.33
Shares outstanding: 28133538
Book value: -6782000
Market cap (USD): 37417605.54
Debt to equity: -159.5041285756414
Current ratio: 1.3044873401855102
Quick ratio: 1.2608423163700175
Interest coverage ratio: 0.4893828197322085
COGS to revenue (%): 56.987826694009335
SG&A to revenue (%): 25.175443954797327
Free cash flow (dilution-adjusted): -17068000
Buyback yield (%): 10.626013991594396
Retained earnings: -205950000
Inventory turnover: 93.7754164273406
Receivables turnover: 47.911614683501966
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.80369389531153
FCF margin (%): -2.978838518259959
Revenue growth (%): -0.5111829962199546
Rule of 40 score: -3.4900215144799134
Financial ratios for CXH — annual report dated 2021-11-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 7.91
Shares outstanding: 4099610
Market cap (USD): 32427915.1
Buyback yield (%): 150.33343910537127
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CXH — annual report dated 2022-11-30
Total revenue: -18167043
Net income: -18339136
Capital expenditures: 0
Operating cash flow: -302265
Net tangible assets: 76685028
Owner earnings: -18339136
Return on net tangible assets (%): -23.91488466301401
Buffett classification: The Gruesome
Stock price: 6.14
Shares outstanding: 4099610
Book value: 76685028
P/B ratio: 0.32824667417478154
Market cap (USD): 25171605.4
Debt to equity: 0
Free cash flow (dilution-adjusted): -302265
Buyback yield (%): 0
Retained earnings: -8683172
Receivables turnover: -10.231011261012657
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CXH — annual report dated 2023-11-30
Total revenue: 1862115
Net income: 1572930
Capital expenditures: 0
Operating cash flow: 11841908
Net tangible assets: 68795142
Owner earnings: 1572930
Return on net tangible assets (%): 2.2863969086654405
Buffett classification: The Gruesome
Stock price: 6.36
P/E ratio: 16.57640174705804
Shares outstanding: 4099610
Book value: 68795142
P/B ratio: 0.3790023371126991
Market cap (USD): 26073519.6
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 21.849402426810375
Free cash flow (dilution-adjusted): 11841908
Buyback yield (%): 45.850215787514934
Retained earnings: -9579277
Receivables turnover: 1.1095714589606067
Capitalized R&D asset: 0
FCF margin (%): 635.938596703211
Rule of 40 score: 635.938596703211
Financial ratios for CXH — annual report dated 2024-11-30
Total revenue: 1010959.4
Net income: 7253132
Capital expenditures: 0
Operating cash flow: 2432392
Net tangible assets: 73568010
Owner earnings: 7253132
Return on net tangible assets (%): 9.859084131812184
Buffett classification: The Gruesome
Stock price: 7.5
P/E ratio: 4.2391445516226645
Shares outstanding: 4099610
Book value: 73568010
P/B ratio: 0.41794082781361086
Market cap (USD): 30747075
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 27.585677525724574
Free cash flow (dilution-adjusted): 2432392
Buyback yield (%): 21.74795813910754
Retained earnings: -4787429
Receivables turnover: 0.5771284679050024
Capitalized R&D asset: 0
FCF margin (%): 240.60234268557173
Revenue growth (%): -45.70907811816134
Rule of 40 score: 194.8932645674104
Financial ratios for CXH — quarterly report dated 2024-11-30
Capital expenditures: 0
Net tangible assets: 73568010
Buffett classification: The Gruesome
Stock price: 7.5
Shares outstanding: 4099610
Book value: 73568010
P/B ratio: 0.41794082781361086
Market cap (USD): 30747075
Debt to equity: 0
Buyback yield (%): 0
Retained earnings: -4787429
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CXH — quarterly report dated 2025-05-31
Capital expenditures: 0
Net tangible assets: 67390385
Buffett classification: The Gruesome
Stock price: 7.04
Shares outstanding: 4099610
Book value: 67390385
P/B ratio: 0.42826961739423214
Market cap (USD): 28861254.4
Debt to equity: 0
Buyback yield (%): 0
Retained earnings: -10965054
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DCBO.TO — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 66.8267716535433
Shares outstanding: 25382651
Market cap (USD): 1696240622.3385825
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DCBO.TO — annual report dated 2022-12-31
Total revenue: 105082352.94117646
Gross profit: 84363235.29411764
Operating income: -5093382.352941176
Net income: 5160294.117647058
Capital expenditures: 794852.9411764705
Operating cash flow: 1682352.9411764704
Depreciation & amortization: 1715441.1764705882
Net tangible assets: 136087500
Owner earnings: 6080882.352941176
Return on net tangible assets (%): 4.468362158861891
Buffett classification: The Gruesome
Stock price: 32.89705882352941
P/E ratio: 161.81530432316902
Shares outstanding: 25382651
Book value: 141331617.64705884
P/B ratio: 5.908193629604964
Market cap (USD): 835014563.0441177
Debt to equity: 0.01595122027355354
Current ratio: 3.1244517673834196
Quick ratio: 3.1244517673834196
Effective tax rate (%): 9.817527627859162
Interest coverage ratio: -18.42287234042553
COGS to revenue (%): 19.717028660994178
R&D to revenue (%): 17.337942230183607
SG&A to revenue (%): 66.1595947156292
Free cash flow (dilution-adjusted): -2577941.176470588
Buyback yield (%): 0
Retained earnings: -55051470.58823529
Receivables turnover: 3.764606711975133
Capitalized R&D asset: 18219117.647058822
ROCI (R&D-adjusted, %): 4.280369800150241
FCF margin (%): -2.4532579489476043
Rule of 40 score: -2.4532579489476043
Financial ratios for DCBO.TO — annual report dated 2023-12-31
Total revenue: 136999242.4242424
Gross profit: 110864393.93939394
Operating income: 515151.51515151514
Net income: 2151515.1515151514
Capital expenditures: 481060.606060606
Operating cash flow: 12093939.393939393
Depreciation & amortization: 2379545.4545454546
Net tangible assets: 25809848.484848484
Owner earnings: 4049999.9999999995
Return on net tangible assets (%): 15.691684522586513
Capex to operating income (%): 93.38235294117646
Buffett classification: The Gruesome
Stock price: 48.47727272727273
P/E ratio: 571.9140272852112
Shares outstanding: 25382651
Book value: 38424999.999999985
P/B ratio: 32.022945870349574
Market cap (USD): 1230481695.0681818
Debt to equity: 0.04158041048086593
Current ratio: 1.2632933275046696
Quick ratio: 1.2632933275046696
Effective tax rate (%): 41.39496491952126
Interest coverage ratio: 2.2972972972972974
COGS to revenue (%): 19.076637229801097
R&D to revenue (%): 19.619108709957477
SG&A to revenue (%): 59.191324880142005
Free cash flow (dilution-adjusted): 7030303.030303029
Buyback yield (%): 9.816801003874026
Retained earnings: -155143181.8181818
Receivables turnover: 4.231240787103114
Capitalized R&D asset: 39084839.12655971
ROCI (R&D-adjusted, %): 14.925908380139472
Rosenberg metric: 1.454579698021461
FCF margin (%): 5.131636427982902
Revenue growth (%): 30.3732154731371
Rule of 40 score: 35.504851901120006
Financial ratios for DCBO.TO — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 519259.2592592592
Buffett classification: The Gruesome
Stock price: 44.2074074074074
Shares outstanding: 25382651
Market cap (USD): 1122101193.8370368
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DCBO.TO — quarterly report dated 2024-12-31
Capital expenditures: 0
Depreciation & amortization: 484615.3846153846
Buffett classification: The Gruesome
Stock price: 45.07692307692307
Shares outstanding: 25382651
Market cap (USD): 1144171806.6153846
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DCBO.TO — annual report dated 2024-12-31
Total revenue: 151700000
Gross profit: 122822377.62237763
Operating income: 13221678.321678322
Net income: 18696503.4965035
Capital expenditures: 870629.3706293707
Operating cash flow: 20453846.153846156
Depreciation & amortization: 2366433.5664335666
Net tangible assets: 29535664.335664336
Owner earnings: 20192307.692307696
Return on net tangible assets (%): 68.36584903873474
Capex to operating income (%): 6.584862749246312
Buffett classification: The Great
Stock price: 45.07692307692307
P/E ratio: 61.19710066801316
Shares outstanding: 25382651
Book value: 40392307.692307696
P/B ratio: 28.32647778708817
Market cap (USD): 1144171806.6153846
Debt to equity: 0.025882515884420282
Current ratio: 1.1993670393928555
Quick ratio: 1.1993670393928555
Effective tax rate (%): -12.748281533336147
Interest coverage ratio: 102.19999999999999
COGS to revenue (%): 19.036006840884887
R&D to revenue (%): 20.240537313708046
SG&A to revenue (%): 50.4478382527163
Free cash flow (dilution-adjusted): 14457342.65734266
Buyback yield (%): 0.6737703957149098
Retained earnings: -143613986.01398602
Receivables turnover: 4.75705012938029
Capitalized R&D asset: 54725484.23145483
ROCI (R&D-adjusted, %): 19.009039599321383
Rosenberg metric: 0.4448980653777863
FCF margin (%): 9.530219286316848
Revenue growth (%): 10.730539319505208
Rule of 40 score: 20.260758605822055
Financial ratios for DCBO.TO — quarterly report dated 2025-03-31
Total revenue: 40067132.86713287
Gross profit: 32098601.3986014
Operating income: 1280419.5804195805
Net income: 1030769.2307692309
Capital expenditures: 208391.6083916084
Operating cash flow: 5555944.055944056
Depreciation & amortization: 558041.958041958
Net tangible assets: 25782517.482517485
Owner earnings: 1380419.5804195807
Return on net tangible assets (%): 5.3540915131953675
Capex to operating income (%): 16.275259421081376
Buffett classification: The Great
Stock price: 28.944055944055947
P/E ratio: 178.1865544250339
Shares outstanding: 25382651
Book value: 36666433.566433564
P/B ratio: 20.03676930349208
Market cap (USD): 734676870.5524477
Debt to equity: 0.02141780939484676
Current ratio: 1.1508188324345858
Quick ratio: 1.1508188324345858
Effective tax rate (%): 37.462876537972
Interest coverage ratio: 59.06451612903226
COGS to revenue (%): 19.887950293214185
R&D to revenue (%): 23.39255794470818
SG&A to revenue (%): 52.131038815973184
Free cash flow (dilution-adjusted): 4795804.195804196
Buyback yield (%): 0.8954034000519225
Retained earnings: -146001398.60139862
Receivables turnover: 1.1228125183719064
Capitalized R&D asset: 9372727.272727273
ROCI (R&D-adjusted, %): 15.26922895097623
FCF margin (%): 11.969421949176208
Rule of 40 score: 11.969421949176208
Financial ratios for DCBO.TO — quarterly report dated 2025-06-30
Total revenue: 44329927.00729927
Gross profit: 35874452.55474452
Operating income: 3709489.05109489
Net income: 2245255.4744525547
Capital expenditures: 210218.97810218975
Operating cash flow: 4557664.233576642
Depreciation & amortization: 618248.1751824816
Net tangible assets: 13724087.591240875
Owner earnings: 2653284.6715328465
Return on net tangible assets (%): 19.33304967556643
Capex to operating income (%): 5.667060212514758
Buffett classification: The Great
Stock price: 28.81021897810219
P/E ratio: 223.22167851455112
Shares outstanding: 25382651
Book value: 25316788.32116787
P/B ratio: 28.885169962230435
Market cap (USD): 731279733.5547445
Debt to equity: 0.03961480798062508
Current ratio: 1.0377145472576093
Quick ratio: 1.0377145472576093
Effective tax rate (%): 34.31560965193252
Interest coverage ratio: 195.46153846153845
COGS to revenue (%): 19.07396430218007
R&D to revenue (%): 20.909899229401304
SG&A to revenue (%): 50.25357307514984
Free cash flow (dilution-adjusted): 3082481.7518248167
Buyback yield (%): 3.4144721807505407
Retained earnings: -160425547.44525546
Receivables turnover: 1.2368790859656627
Capitalized R&D asset: 15549070.338420704
ROCI (R&D-adjusted, %): 15.083252613418368
Rosenberg metric: 0.4028551185021755
FCF margin (%): 6.953500625699795
Revenue growth (%): 10.639129468790042
Rule of 40 score: 17.592630094489838
Financial ratios for DCBO.TO — quarterly report dated 2025-09-30
Total revenue: 44332374.10071943
Gross profit: 35604316.54676259
Operating income: 5858992.805755396
Net income: 4394964.028776979
Capital expenditures: 160431.654676259
Operating cash flow: 3807913.6690647486
Depreciation & amortization: 534532.3741007195
Net tangible assets: 21229496.4028777
Owner earnings: 4769064.74820144
Return on net tangible assets (%): 22.464332915381753
Capex to operating income (%): 2.7382121807465616
Buffett classification: The Great
Stock price: 27.31654676258993
P/E ratio: 90.38813600741128
Shares outstanding: 25382651
Book value: 32544604.316546768
P/B ratio: 21.305109942524922
Market cap (USD): 693366373
Debt to equity: 0.06421734420938612
Current ratio: 1.1342220900650875
Quick ratio: 1.1342220900650875
Effective tax rate (%): 25.915595440213433
Interest coverage ratio: 180.9777777777778
COGS to revenue (%): 19.687773847002692
R&D to revenue (%): 19.31939891597157
SG&A to revenue (%): 46.57102982700983
Free cash flow (dilution-adjusted): 2262589.928057554
Buyback yield (%): 0.3522590852795031
Retained earnings: -151483453.23741007
Receivables turnover: 1.3136498326547144
Capitalized R&D asset: 17868208.05545345
ROCI (R&D-adjusted, %): 9.666734877456726
Rosenberg metric: -0.029142950699680203
FCF margin (%): 5.103696731686735
Revenue growth (%): 0.005520183734477759
Rule of 40 score: 5.1092169154212135
Financial ratios for DCBO.TO — quarterly report dated 2025-12-31
Total revenue: 46012408.759124085
Gross profit: 36713138.68613138
Operating income: 6877372.262773722
Net income: 19600729.9270073
Capital expenditures: 125547.44525547445
Operating cash flow: 6343795.6204379555
Depreciation & amortization: 582481.7518248175
Net tangible assets: 42716058.39416058
Owner earnings: 20057664.233576644
Return on net tangible assets (%): 46.95579364672511
Capex to operating income (%): 1.825514752706432
Buffett classification: The Great
Stock price: 22.25547445255474
P/E ratio: 20.713873881235383
Shares outstanding: 25382651
Book value: 54081021.897810206
P/B ratio: 10.445493096192521
Market cap (USD): 564902940.868613
Debt to equity: 0.03455210484404314
Current ratio: 1.2239517282045895
Quick ratio: 1.2239517282045895
Effective tax rate (%): -193.1870291516541
Interest coverage ratio: 214.13636363636363
COGS to revenue (%): 20.210352650030934
R&D to revenue (%): 19.215698716626743
SG&A to revenue (%): 44.361248155844976
Free cash flow (dilution-adjusted): 5086131.386861313
Buyback yield (%): 0.005168512708940128
Retained earnings: -134332846.71532845
Receivables turnover: 1.1238545195221965
Capitalized R&D asset: 17638870.34605892
ROCI (R&D-adjusted, %): 8.74013088458057
Rosenberg metric: 0.12946348372302516
FCF margin (%): 11.053825531037326
Revenue growth (%): 3.7896338567110304
Rule of 40 score: 14.843459387748357
Financial ratios for DCBO.TO — annual report dated 2025-12-31
Total revenue: 177143795.62043795
Gross profit: 142216058.39416057
Operating income: 17867883.21167883
Net income: 27381021.897810217
Capital expenditures: 716058.3941605838
Operating cash flow: 20564233.576642334
Depreciation & amortization: 2325547.445255474
Net tangible assets: 42716058.39416058
Owner earnings: 28990510.948905107
Return on net tangible assets (%): 67.86794484031373
Capex to operating income (%): 4.007516646921851
Buffett classification: The Great
Stock price: 22.25547445255474
P/E ratio: 20.63118546038601
Shares outstanding: 25382651
Book value: 54081021.897810206
P/B ratio: 10.445493096192521
Market cap (USD): 564902940.868613
Debt to equity: 0.03455210484404314
Current ratio: 1.2239517282045895
Quick ratio: 1.2239517282045895
Effective tax rate (%): -53.45469421149519
Interest coverage ratio: 167.66438356164383
COGS to revenue (%): 19.717166556099006
R&D to revenue (%): 20.65211568810855
SG&A to revenue (%): 48.23126084215471
Free cash flow (dilution-adjusted): 15470072.99270073
Buyback yield (%): 6.0794630738908255
Retained earnings: -134332846.71532845
Receivables turnover: 4.326742734890355
Capitalized R&D asset: 66025971.32611914
ROCI (R&D-adjusted, %): 18.231666420104663
Rosenberg metric: 0.6316152752038261
FCF margin (%): 8.733059455183014
Revenue growth (%): 16.77244272935923
Rule of 40 score: 25.505502184542244
Financial ratios for DLN.L — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.38648648648648654
Shares outstanding: 110963655
Market cap (USD): 42885953.14864866
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DLN.L — annual report dated 2022-12-31
Total revenue: 300361445.78313255
Gross profit: 233493975.90361446
Operating income: 189638554.21686748
Net income: -337951807.2289157
Capital expenditures: 2409638.554216868
Operating cash flow: 134216867.46987952
Depreciation & amortization: 1204819.277108434
Net tangible assets: 4910240963.855422
Owner earnings: -339156626.5060241
Return on net tangible assets (%): -6.9071279597595385
Capex to operating income (%): 1.270648030495553
Buffett classification: The Great
Stock price: 0.24554216867469877
Shares outstanding: 110963655
Book value: 4910240963.855421
P/B ratio: 0.005548863425101215
Market cap (USD): 27246256.49277108
Debt to equity: 0.3150779045515888
Current ratio: 0.9462174940898346
Quick ratio: 0.6997635933806147
Interest coverage ratio: 4.360110803324099
COGS to revenue (%): 22.26233453670277
SG&A to revenue (%): 14.600882470918572
Free cash flow (dilution-adjusted): -16144578.313253013
Buyback yield (%): 0
Retained earnings: 3531807228.915663
Inventory turnover: 1.330935251798561
Receivables turnover: 50.87755102040816
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.9474551514924534
FCF margin (%): -5.375050140393101
Rule of 40 score: -5.375050140393101
Financial ratios for DLN.L — annual report dated 2023-12-31
Total revenue: 336708860.75949365
Gross profit: 244936708.8607595
Operating income: 195443037.97468352
Net income: -603037974.6835443
Capital expenditures: 886075.9493670886
Operating cash flow: 122784810.12658228
Depreciation & amortization: 1392405.0632911392
Net tangible assets: 4441518987.341772
Owner earnings: -602531645.5696201
Return on net tangible assets (%): -13.565891472868213
Capex to operating income (%): 0.45336787564766845
Buffett classification: The Great
Stock price: 0.2665822784810126
Shares outstanding: 110963655
Book value: 4441518987.341772
P/B ratio: 0.006660096255984952
Market cap (USD): 29580943.97848101
Debt to equity: 0.3906463748290014
Current ratio: 0.73587907716786
Quick ratio: 0.46181384248210017
Interest coverage ratio: 4.195652173913043
COGS to revenue (%): 27.25563909774436
SG&A to revenue (%): 14.699248120300751
Free cash flow (dilution-adjusted): -73037974.6835443
Buyback yield (%): 0
Retained earnings: 2996582278.4810123
Inventory turnover: 1.0522496371552974
Receivables turnover: 25.576923076923077
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.2324247372608133
FCF margin (%): -21.691729323308266
Revenue growth (%): 12.101225202719498
Rule of 40 score: -9.590504120588768
Financial ratios for DLN.L — annual report dated 2024-12-31
Total revenue: 347125000
Gross profit: 248375000
Operating income: 197000000
Net income: 144875000
Capital expenditures: 2000000
Operating cash flow: 80750000
Depreciation & amortization: 1250000
Net tangible assets: 4424750000
Owner earnings: 144125000
Return on net tangible assets (%): 3.2572461721001185
Capex to operating income (%): 1.015228426395939
Buffett classification: The Great
Stock price: 0.227
P/E ratio: 0.1738653990336497
Shares outstanding: 110963655
Book value: 4424750000
P/B ratio: 0.005692694431323804
Market cap (USD): 25188749.685000002
Debt to equity: 0.42321600090400585
Current ratio: 0.7130481862479697
Quick ratio: 0.35246345425013537
Effective tax rate (%): 0.08620689655172414
Interest coverage ratio: 4.306010928961749
COGS to revenue (%): 28.447965430320487
SG&A to revenue (%): 14.800144040331292
Free cash flow (dilution-adjusted): -100000000
Buyback yield (%): 0
Retained earnings: 2993000000
Inventory turnover: 0.5930930930930931
Receivables turnover: 20.8796992481203
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.253106551624489
FCF margin (%): -28.808066258552394
Revenue growth (%): 3.0935150375939915
Rule of 40 score: -25.714551220958402
Financial ratios for DLN.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 4424750000
Buffett classification: The Gruesome
Stock price: 0.227
Shares outstanding: 110963655
Book value: 4424750000
P/B ratio: 0.005692694431323804
Market cap (USD): 25188749.685000002
Debt to equity: 0.42321600090400585
Current ratio: 0.7130481862479697
Quick ratio: 0.35246345425013537
Buyback yield (%): 0
Retained earnings: 2993000000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DLN.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 4898356164.383562
Buffett classification: The Gruesome
Stock price: 0.2708219178082192
Shares outstanding: 110963655
Book value: 4898356164.383562
P/B ratio: 0.006134994852480563
Market cap (USD): 30051389.85410959
Debt to equity: 0.44336931595726825
Current ratio: 0.6580568720379147
Quick ratio: 0.3563981042654028
Buyback yield (%): 0
Retained earnings: 3325890410.9589043
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EFF0.DE — annual report dated 2021-12-31
Total revenue: 5681.818181818182
Gross profit: -880681.8181818182
Operating income: 9245454.545454545
Net income: 8568181.818181818
Capital expenditures: 0
Depreciation & amortization: 2272.7272727272725
Net tangible assets: 24181818.181818184
Owner earnings: 8570454.545454545
Return on net tangible assets (%): 35.441729323308266
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 24.318181818181817
P/E ratio: 4.753978779840849
Shares outstanding: 1675000
Book value: 24186363.636363633
P/B ratio: 1.6841289231347492
Market cap (USD): 40732954.54545454
Debt to equity: 0.5891749671114453
Current ratio: 184.875
Quick ratio: 184.875
Effective tax rate (%): 0
Interest coverage ratio: 14.554561717352415
COGS to revenue (%): 15600
Buyback yield (%): 0
Retained earnings: -20190909.09090909
Receivables turnover: 0.003610108303249097
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 23.00514618560199
Rule of 40 score: 0
Financial ratios for EFF0.DE — annual report dated 2022-12-31
Total revenue: 0
Gross profit: -420212.7659574468
Operating income: -940425.5319148937
Net income: -5110638.29787234
Capital expenditures: 0
Depreciation & amortization: 2127.6595744680853
Net tangible assets: 17527659.574468087
Owner earnings: -5108510.638297873
Return on net tangible assets (%): -29.145423646516143
Buffett classification: The Gruesome
Stock price: 11.702127659574469
Shares outstanding: 1675000
Book value: 17531914.893617027
P/B ratio: 1.118021844660194
Market cap (USD): 19601063.829787236
Debt to equity: 1.079672330097087
Current ratio: 1.000941265060241
Quick ratio: 1.000941265060241
Interest coverage ratio: -1.80040733197556
Buyback yield (%): 0
Retained earnings: -24012765.95744681
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.898075599121398
Revenue growth (%): -100
Rule of 40 score: -100
Financial ratios for EFF0.DE — annual report dated 2023-12-31
Total revenue: 0
Gross profit: -486666.6666666666
Operating income: -802222.2222222222
Net income: -1804444.4444444445
Capital expenditures: 0
Depreciation & amortization: 4444.444444444444
Net tangible assets: 16502222.222222222
Owner earnings: -1800000
Return on net tangible assets (%): -10.907621869108537
Buffett classification: The Gruesome
Stock price: 7.666666666666667
Shares outstanding: 1675000
Book value: 16506666.666666668
P/B ratio: 0.7779684975767367
Market cap (USD): 12841666.666666668
Debt to equity: 1.035810446957458
Current ratio: 0.1761388766032729
Quick ratio: 0.1761388766032729
Interest coverage ratio: -0.879415347137637
Buyback yield (%): 0
Retained earnings: -26884444.444444444
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.1578026592022392
Rule of 40 score: 0
Financial ratios for EFF0.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 13878125
Buffett classification: The Gruesome
Stock price: 4.875
Shares outstanding: 1675000
Book value: 13882291.666666664
P/B ratio: 0.5882043970886172
Market cap (USD): 8165625
Debt to equity: 1.236362272079238
Current ratio: 0.1609850782482106
Quick ratio: 0.1609850782482106
Buyback yield (%): 0
Retained earnings: -26796875
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EFF0.DE — annual report dated 2024-12-31
Total revenue: 10416.666666666668
Gross profit: -425000
Operating income: -69791.66666666667
Net income: -1592708.3333333335
Capital expenditures: 0
Depreciation & amortization: 3125
Net tangible assets: 13878125
Owner earnings: -1589583.3333333335
Return on net tangible assets (%): -11.453876754484726
Buffett classification: The Gruesome
Stock price: 4.875
Shares outstanding: 1675000
Book value: 13882291.666666664
P/B ratio: 0.5882043970886172
Market cap (USD): 8165625
Debt to equity: 1.236362272079238
Current ratio: 0.1609850782482106
Quick ratio: 0.1609850782482106
Interest coverage ratio: -0.06399235912129896
COGS to revenue (%): 4180
Buyback yield (%): 0
Retained earnings: -26796875
Receivables turnover: 0.25641025641025644
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.28972972972972977
Rule of 40 score: 0
Financial ratios for EFF0.DE — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 14663529.411764706
Buffett classification: The Gruesome
Stock price: 3.364705882352941
Shares outstanding: 1675000
Book value: 14668235.294117648
P/B ratio: 0.3842236124478665
Market cap (USD): 5635882.352941177
Debt to equity: 1.3747192813602822
Current ratio: 0.5702643171806168
Quick ratio: 0.5702643171806168
Buyback yield (%): 0
Retained earnings: -31275294.11764706
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EUZ.DE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 30.556818181818183
Shares outstanding: 62576524
Market cap (USD): 1912139466.318182
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EUZ.DE — annual report dated 2022-12-31
Total revenue: 236413829.78723407
Gross profit: 113565957.44680852
Operating income: 48852127.65957447
Net income: 31645744.680851065
Capital expenditures: 28812765.95744681
Operating cash flow: 36487234.042553194
Depreciation & amortization: 11559574.468085106
Net tangible assets: 122404255.31914894
Owner earnings: 14392553.191489358
Return on net tangible assets (%): 11.758213106205453
Capex to operating income (%): 58.9795518390279
Buffett classification: The Good
Stock price: 14.297872340425533
P/E ratio: 28.272715990183887
Shares outstanding: 62576524
Book value: 227264893.6170213
P/B ratio: 3.936864763491848
Market cap (USD): 894711151.6595745
Debt to equity: 0.23211736234312758
Current ratio: 3.0775951847210212
Quick ratio: 2.3842867985808347
Effective tax rate (%): 30.71688942891859
Interest coverage ratio: 25.900169204737733
COGS to revenue (%): 51.96306512651364
R&D to revenue (%): 1.4269064793523796
SG&A to revenue (%): 9.956396329911938
Free cash flow (dilution-adjusted): 7674468.085106383
Buyback yield (%): 0.042685831389115705
Retained earnings: 131039361.70212767
Inventory turnover: 2.9399918529456697
Receivables turnover: 5.978558553711227
Capitalized R&D asset: 3373404.2553191492
ROCI (R&D-adjusted, %): 13.570205721324166
FCF margin (%): 3.246200990869778
Rule of 40 score: 3.246200990869778
Financial ratios for EUZ.DE — annual report dated 2023-12-31
Total revenue: 273435555.5555555
Gross profit: 126032222.22222222
Operating income: 51757777.777777776
Net income: 29742222.22222222
Capital expenditures: 29195555.555555556
Operating cash flow: 52663333.33333333
Depreciation & amortization: 14860000
Net tangible assets: 192664444.44444445
Owner earnings: 15406666.666666668
Return on net tangible assets (%): 7.996632025744242
Capex to operating income (%): 56.40805461336997
Buffett classification: The Good
Stock price: 13.477777777777778
P/E ratio: 28.356740739689183
Shares outstanding: 62576524
Book value: 248992222.2222222
P/B ratio: 3.3872242154819654
Market cap (USD): 843392484.5777777
Debt to equity: 0.2512528280669187
Current ratio: 2.792065483658959
Quick ratio: 2.3148712433530503
Effective tax rate (%): 27.948754313808916
Interest coverage ratio: 11.665915351865763
COGS to revenue (%): 53.90788810688687
R&D to revenue (%): 1.7599109276205647
SG&A to revenue (%): 10.281114379987972
Free cash flow (dilution-adjusted): 22565555.555555552
Buyback yield (%): 0.04373869765671002
Retained earnings: 154523333.33333334
Inventory turnover: 3.32205639304853
Receivables turnover: 5.628819762122598
Capitalized R&D asset: 7072403.073286053
ROCI (R&D-adjusted, %): 13.384364958830366
Rosenberg metric: 3.695455341812956
FCF margin (%): 8.25260471693513
Revenue growth (%): 15.659712378772422
Rule of 40 score: 23.91231709570755
Financial ratios for EUZ.DE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 14.655555555555555
Shares outstanding: 62576524
Market cap (USD): 917093723.9555556
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EUZ.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 15.114583333333334
Shares outstanding: 62576524
Market cap (USD): 945818086.7083334
Buyback yield (%): 0.030396965763317844
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EUZ.DE — annual report dated 2024-12-31
Total revenue: 308177083.3333334
Gross profit: 149120833.33333334
Operating income: 70026041.66666667
Net income: 35529166.66666667
Capital expenditures: 17909375
Operating cash flow: 69345833.33333334
Depreciation & amortization: 19639583.333333336
Net tangible assets: 181071875
Owner earnings: 37259375.00000001
Return on net tangible assets (%): 20.577118892704902
Capex to operating income (%): 25.575306805503907
Buffett classification: The Good
Stock price: 15.114583333333334
P/E ratio: 26.620891381494072
Shares outstanding: 62576524
Book value: 234596875
P/B ratio: 4.031673852042289
Market cap (USD): 945818086.7083334
Debt to equity: 0.24571849760004974
Current ratio: 3.1206607679419545
Quick ratio: 2.512565945249865
Effective tax rate (%): 29.970529778630667
Interest coverage ratio: 17.945808862786972
COGS to revenue (%): 51.612641541321615
R&D to revenue (%): 1.6430623626837924
SG&A to revenue (%): 9.424708467128612
Free cash flow (dilution-adjusted): 49403125
Buyback yield (%): 0.08215991470809823
Retained earnings: 133331250
Inventory turnover: 3.4770015484106023
Receivables turnover: 6.846002545412474
Capitalized R&D asset: 9400953.959810875
ROCI (R&D-adjusted, %): 17.891857442350943
Rosenberg metric: 4.797910413299471
FCF margin (%): 16.03075883048842
Revenue growth (%): 12.705563366545872
Rule of 40 score: 28.73632219703429
Financial ratios for EUZ.DE — quarterly report dated 2025-03-31
Total revenue: 74123913.04347825
Gross profit: 37045652.17391304
Operating income: 17115217.391304348
Net income: 10685869.56521739
Capital expenditures: 5281521.739130435
Operating cash flow: 7557608.695652174
Depreciation & amortization: 3493478.260869565
Net tangible assets: 197793478.26086956
Owner earnings: 8897826.08695652
Return on net tangible assets (%): 4.498543715997141
Capex to operating income (%): 30.85863076336847
Buffett classification: The Good
Stock price: 19.684782608695652
P/E ratio: 28.818554817414306
Shares outstanding: 62576524
Book value: 252981521.7391304
P/B ratio: 4.86915116519079
Market cap (USD): 1231805271.347826
Debt to equity: 0.22838925338248625
Current ratio: 3.0785805141910036
Quick ratio: 2.4588660045483164
Effective tax rate (%): 34.19907624338978
Interest coverage ratio: 21.718620689655175
COGS to revenue (%): 50.02199607003549
SG&A to revenue (%): 25.701674634132036
Free cash flow (dilution-adjusted): 2276086.9565217393
Buyback yield (%): 0
Retained earnings: 149663043.47826087
Inventory turnover: 0.7072336367217466
Receivables turnover: 1.2317390361968066
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.212097542185176
FCF margin (%): 3.070651376953985
Rule of 40 score: 3.070651376953985
Financial ratios for EUZ.DE — quarterly report dated 2025-06-30
Total revenue: 94835294.11764707
Gross profit: 46342352.941176474
Operating income: 21798823.529411767
Net income: 13975294.11764706
Capital expenditures: 6457647.05882353
Operating cash flow: 17790588.23529412
Depreciation & amortization: 5507058.823529412
Net tangible assets: 209550588.23529413
Owner earnings: 13024705.88235294
Return on net tangible assets (%): 6.215542505530041
Capex to operating income (%): 29.623832910572613
Buffett classification: The Good
Stock price: 26.352941176470587
P/E ratio: 66.86932852020453
Shares outstanding: 62576524
Book value: 265961176.4705882
P/B ratio: 6.200436762552695
Market cap (USD): 1649075456
Debt to equity: 0.21486550447433728
Current ratio: 3.0372508483831964
Quick ratio: 2.9997399591735903
Effective tax rate (%): 32.540178317905614
Interest coverage ratio: 15.225143796220214
COGS to revenue (%): 51.133854360501175
SG&A to revenue (%): 23.504527974196748
Free cash flow (dilution-adjusted): 11332941.176470589
Buyback yield (%): 0
Retained earnings: 163490588.23529413
Inventory turnover: 14.287348353552861
Receivables turnover: 767.7142857142858
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.118875941365955
FCF margin (%): 11.95013025679196
Revenue growth (%): 27.941564636530064
Rule of 40 score: 39.891694893322025
Financial ratios for EUZ.DE — quarterly report dated 2025-09-30
Total revenue: 88603529.41176471
Gross profit: 40178823.52941176
Operating income: 18012941.17647059
Net income: 10100000
Capital expenditures: 8204705.882352942
Operating cash flow: 20689411.76470588
Depreciation & amortization: 5002352.94117647
Net tangible assets: 218896470.5882353
Owner earnings: 6897647.058823529
Return on net tangible assets (%): 3.1511001709107713
Capex to operating income (%): 45.548951734047414
Buffett classification: The Good
Stock price: 20.67058823529412
P/E ratio: 37.210882023424006
Shares outstanding: 62576524
Book value: 274295294.11764705
P/B ratio: 4.71569723775579
Market cap (USD): 1293493560.8000002
Debt to equity: 0.1990684148899211
Current ratio: 2.9286783460465333
Quick ratio: 2.371109700750817
Effective tax rate (%): 38.72671472414532
Interest coverage ratio: 13.573581560283689
COGS to revenue (%): 54.65324711537184
SG&A to revenue (%): 24.140586618512074
Free cash flow (dilution-adjusted): 12484705.88235294
Buyback yield (%): 0
Retained earnings: 173440000
Inventory turnover: 0.8840041235342124
Receivables turnover: 1.4998108135019417
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.154603004903251
FCF margin (%): 14.090528859559438
Revenue growth (%): -6.571145019228386
Rule of 40 score: 7.519383840331052
Financial ratios for EUZ.DE — quarterly report dated 2025-12-31
Total revenue: 103345882.35294119
Gross profit: 53358823.52941176
Operating income: 30223529.411764707
Net income: 22278823.529411767
Capital expenditures: 10232941.176470589
Operating cash flow: 22052941.17647059
Depreciation & amortization: 5794117.647058824
Net tangible assets: 242449411.7647059
Owner earnings: 17840000.000000004
Return on net tangible assets (%): 7.358236041963879
Capex to operating income (%): 33.857532113662906
Buffett classification: The Good
Stock price: 17.694117647058825
P/E ratio: 19.41158179926273
Shares outstanding: 62576524
Book value: 298142352.9411764
P/B ratio: 3.7137842600258075
Market cap (USD): 1107236377.6000001
Debt to equity: 0.17680065977168433
Current ratio: 3.45440867105978
Quick ratio: 2.8139427966396853
Effective tax rate (%): 27.74343711843712
Interest coverage ratio: 18.194050991501417
COGS to revenue (%): 48.36983743909658
SG&A to revenue (%): -19.808979554665086
Free cash flow (dilution-adjusted): 11820000
Buyback yield (%): 0.06778934024196909
Retained earnings: 195687058.82352942
Inventory turnover: 0.9242582441486122
Receivables turnover: 1.9539125405934428
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.652906794562694
FCF margin (%): 11.437320704885934
Revenue growth (%): 16.638561735689724
Rule of 40 score: 28.075882440575658
Financial ratios for EUZ.DE — annual report dated 2025-12-31
Total revenue: 367011764.7058824
Gross profit: 179975294.11764705
Operating income: 88560000
Net income: 57918823.52941176
Capital expenditures: 30611764.705882356
Operating cash flow: 68712941.1764706
Depreciation & amortization: 20084705.88235294
Net tangible assets: 242449411.7647059
Owner earnings: 47391764.705882356
Return on net tangible assets (%): 19.547073495016548
Capex to operating income (%): 34.56612997502525
Buffett classification: The Good
Stock price: 17.694117647058825
P/E ratio: 19.117038470882168
Shares outstanding: 62576524
Book value: 298142352.9411764
P/B ratio: 3.7137842600258075
Market cap (USD): 1107236377.6000001
Debt to equity: 0.17680065977168433
Current ratio: 3.45440867105978
Quick ratio: 2.8139427966396853
Effective tax rate (%): 32.344331908694876
Interest coverage ratio: 16.795180722891565
COGS to revenue (%): 50.96230285934094
R&D to revenue (%): 1.6354660853955636
SG&A to revenue (%): 9.145403256827798
Free cash flow (dilution-adjusted): 38101176.47058824
Buyback yield (%): 0.06778934024196909
Retained earnings: 195687058.82352942
Inventory turnover: 3.4582354476637955
Receivables turnover: 6.9389207704969085
Capitalized R&D asset: 10982959.191176472
ROCI (R&D-adjusted, %): 19.18648670764211
Rosenberg metric: 6.093454505850886
FCF margin (%): 10.381459161430953
Revenue growth (%): 19.091192873972293
Rule of 40 score: 29.472652035403247
Financial ratios for FRB.AX — annual report dated 2021-06-30
Operating income: -2551996.2406015038
Net income: -2552587.2180451127
Capital expenditures: 582466.1654135338
Depreciation & amortization: 3693.984962406015
Net tangible assets: 3715296.2406015038
Owner earnings: -3131359.3984962404
Return on net tangible assets (%): -84.28289955121521
Buffett classification: The Gruesome
Stock price: 0.46616541353383456
Shares outstanding: 182361401
Book value: 3715296.2406015038
P/B ratio: 22.881238104450937
Market cap (USD): 85010577.90977444
Debt to equity: 0.022944364933912716
Current ratio: 19.272733541177228
Quick ratio: 19.272733541177228
Interest coverage ratio: -4318.263358778626
Free cash flow (dilution-adjusted): -810412.7819548872
Buyback yield (%): 0.5517685747686302
Retained earnings: -5512278.195488721
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -67.91391933659496
Rule of 40 score: 0
Financial ratios for FRB.AX — annual report dated 2022-06-30
Operating income: -893840
Net income: -809138.6206896552
Capital expenditures: 11862.068965517241
Depreciation & amortization: 42499.31034482759
Net tangible assets: 2718095.8620689656
Owner earnings: -778501.3793103448
Return on net tangible assets (%): -28.641424689038143
Buffett classification: The Gruesome
Stock price: 0.1724137931034483
Shares outstanding: 182361401
Book value: 2718095.8620689656
P/B ratio: 11.567517283270567
Market cap (USD): 31441620.862068966
Debt to equity: 0.014306668537482756
Current ratio: 3.478545093219674
Quick ratio: 3.478545093219674
Interest coverage ratio: -184.8884450784593
Free cash flow (dilution-adjusted): -2236848.275862069
Buyback yield (%): 0
Retained earnings: -5865228.275862069
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -32.884785723474266
Rule of 40 score: 0
Financial ratios for FRB.AX — annual report dated 2023-06-30
Operating income: -843927.1523178808
Net income: -630550.9933774834
Capital expenditures: 1050879.4701986755
Depreciation & amortization: 38641.05960264901
Net tangible assets: 4231436.423841059
Owner earnings: -1642789.40397351
Return on net tangible assets (%): -38.823445265952465
Buffett classification: The Gruesome
Stock price: 0.059602649006622516
Shares outstanding: 182361401
Book value: 4231436.423841059
P/B ratio: 2.5686838906331655
Market cap (USD): 10869222.57615894
Debt to equity: 0
Current ratio: 4.280192309422622
Quick ratio: 4.280192309422622
Interest coverage ratio: -558.9166666666666
Free cash flow (dilution-adjusted): -1526903.311258278
Buyback yield (%): 1.4208659820019212
Retained earnings: -6262723.841059603
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -19.944223847083382
Rule of 40 score: 0
Financial ratios for GNTA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 10.96
Shares outstanding: 48216858
Market cap (USD): 528456763.68000007
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GNTA — annual report dated 2022-12-31
Total revenue: 0
Operating income: -11748927.65957447
Net income: -9018896.808510639
Capital expenditures: 28797.872340425532
Operating cash flow: -7891740.425531915
Depreciation & amortization: 6531.914893617021
Net tangible assets: 33125708.5106383
Owner earnings: -9041162.765957447
Return on net tangible assets (%): -27.293492494066605
Buffett classification: The Gruesome
Stock price: 5.5
Shares outstanding: 48216858
Book value: 33125708.5106383
P/B ratio: 8.005646699295006
Market cap (USD): 265192719
Debt to equity: 0
Current ratio: 14.527675356180612
Quick ratio: 14.527675356180612
Free cash flow (dilution-adjusted): -8689405.319148937
Buyback yield (%): 0
Retained earnings: -37729318.08510639
Receivables turnover: 0
Capitalized R&D asset: 5679746.808510639
ROCI (R&D-adjusted, %): -20.453695510291244
Rule of 40 score: 0
Financial ratios for GNTA — annual report dated 2023-12-31
Total revenue: 0
Operating income: -13036602.222222222
Net income: -12939394.444444444
Capital expenditures: 15323.333333333332
Operating cash flow: -12450025.555555556
Depreciation & amortization: 47170
Net tangible assets: 22702507.777777776
Owner earnings: -12907547.777777778
Return on net tangible assets (%): -56.85516289267505
Buffett classification: The Gruesome
Stock price: 4.95
Shares outstanding: 48216858
Book value: 22702507.77777778
P/B ratio: 10.513087339788257
Market cap (USD): 238673447.1
Debt to equity: 0
Current ratio: 12.24693499051358
Quick ratio: 12.24693499051358
Free cash flow (dilution-adjusted): -13287442.222222222
Buyback yield (%): 0
Retained earnings: -52381138.88888889
Receivables turnover: 0
Capitalized R&D asset: 10999253.695035461
ROCI (R&D-adjusted, %): -29.892896225787446
Rule of 40 score: 0
Financial ratios for GNTA — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 13016360.416666668
Buffett classification: The Gruesome
Stock price: 4.35
Shares outstanding: 48216858
Book value: 13016360.416666666
P/B ratio: 16.11382334123418
Market cap (USD): 209743332.29999998
Debt to equity: 0
Current ratio: 6.893988268816907
Quick ratio: 6.893988268816907
Buyback yield (%): 0
Retained earnings: -58391166.66666667
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GNTA — annual report dated 2024-12-31
Total revenue: 0
Operating income: -10171156.25
Net income: -9283848.958333334
Capital expenditures: 4654.166666666667
Operating cash flow: -6500181.25
Depreciation & amortization: 46378.125
Net tangible assets: 13016360.416666668
Owner earnings: -9242125
Return on net tangible assets (%): -71.00391126359726
Buffett classification: The Gruesome
Stock price: 4.35
Shares outstanding: 48216858
Book value: 13016360.416666666
P/B ratio: 16.11382334123418
Market cap (USD): 209743332.29999998
Debt to equity: 0
Current ratio: 6.893988268816907
Quick ratio: 6.893988268816907
Free cash flow (dilution-adjusted): -7387392.708333334
Buyback yield (%): 0
Retained earnings: -58391166.66666667
Receivables turnover: 0
Capitalized R&D asset: 11707567.66347518
ROCI (R&D-adjusted, %): -44.54736045942001
Rule of 40 score: 0
Financial ratios for GRI — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 7770890.5
Shares outstanding: 1770838
Market cap (USD): 13760988191239
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GRI — annual report dated 2022-12-31
Total revenue: 0
Operating income: -2239000
Net income: -3217000
Capital expenditures: 3000
Operating cash flow: -1085000
Depreciation & amortization: 3000
Net tangible assets: -1625000
Owner earnings: -3217000
Buffett classification: The Gruesome
Stock price: 376849.19
Shares outstanding: 1770838
Book value: -1625000
Market cap (USD): 667338865921.22
Debt to equity: -0.41415384615384615
Current ratio: 0.15646940822467403
Quick ratio: 0.15646940822467403
Interest coverage ratio: -3.428790199081164
Free cash flow (dilution-adjusted): -1113000
Buyback yield (%): 1.858126453174965e-05
Retained earnings: -18496000
Capitalized R&D asset: 242000
Rule of 40 score: 0